Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Continued Avoidance of USPSTF Guidelines for Screening Mammography.

Bleyer A, Keen JD.

J Womens Health (Larchmt). 2018 Jul;27(7):850-853. doi: 10.1089/jwh.2018.7197. No abstract available.

PMID:
30020846
2.

Opportunity cost of annual screening mammography.

Keen JD.

Cancer. 2018 Mar 15;124(6):1297-1298. doi: 10.1002/cncr.31197. Epub 2017 Dec 19. No abstract available.

3.

Utilization of Computer-Aided Detection for Digital Screening Mammography in the United States, 2008 to 2016.

Keen JD, Keen JM, Keen JE.

J Am Coll Radiol. 2018 Jan;15(1 Pt A):44-48. doi: 10.1016/j.jacr.2017.08.033. Epub 2017 Oct 6.

PMID:
28993109
4.

Relative Utility or Marginal Positive Predictive Values Accounting for Overdiagnosis Should Guide Optimal Recall Rates.

Keen JD, Keen JE.

AJR Am J Roentgenol. 2017 Aug;209(2):W112-W113. doi: 10.2214/AJR.17.18062. No abstract available.

PMID:
28731816
5.

Given Overdiagnosis, Recall Reduction Should Trump DCIS Detection.

Keen JD, Jørgensen KJ.

Radiology. 2017 Aug;284(2):608-610. doi: 10.1148/radiol.2017170702. No abstract available.

PMID:
28723298
6.

Four Principles to Consider Before Advising Women on Screening Mammography.

Keen JD, Jørgensen KJ.

J Womens Health (Larchmt). 2015 Nov;24(11):867-74. doi: 10.1089/jwh.2015.5220. Epub 2015 Oct 23. Review.

7.

Supporting informed choice before screening mammography is the only ethical option.

Keen JD.

AJR Am J Roentgenol. 2014 Oct;203(4):W460. doi: 10.2214/AJR.14.12881. No abstract available.

PMID:
25247983
8.

Aggregate cost of mammography screening in the United States.

Keen JD.

Ann Intern Med. 2014 Aug 19;161(4):304. doi: 10.7326/L14-5016. No abstract available.

PMID:
25133365
9.

Point/Counterpoint: recent data show that mammographic screening of asymptomatic women is effective and essential.

Javitt MC, Hendrick RE, Keen JD, Jorgensen KJ, Orton CG.

Med Phys. 2012 Jul;39(7):4047-50. doi: 10.1118/1.3694115. No abstract available.

PMID:
22830737
10.

Screen detection has both winners and losers.

Keen JD, Keen J.

Arch Intern Med. 2012 Mar 12;172(5):447. doi: 10.1001/archinternmed.2011.1885. No abstract available.

PMID:
22412118
11.

Comparative effectiveness of digital versus film-screen mammography.

Keen JD.

Ann Intern Med. 2012 Feb 7;156(3):249-50; author reply 251. doi: 10.7326/0003-4819-156-3-201202070-00021. No abstract available.

PMID:
22312149
12.

The Two-County breast screening trial cannot provide a reliable estimate of the effect of breast cancer screening.

Jørgensen KJ, Keen JD, Zahl PH, Gøtzsche PC.

Radiology. 2012 Feb;262(2):729-30; author reply 730-1. doi: 10.1148/radiol.11111756. No abstract available.

PMID:
22282190
13.

Analysis of health benefits and cost-effectiveness of mammography for breast cancer.

Keen JD.

Ann Intern Med. 2011 Oct 18;155(8):566; author reply 566-7. doi: 10.7326/0003-4819-155-8-201110180-00028. No abstract available.

PMID:
22007057
14.

Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality?

Jørgensen KJ, Keen JD, Gøtzsche PC.

Radiology. 2011 Sep;260(3):621-7. doi: 10.1148/radiol.11110210. No abstract available.

PMID:
21846758
15.

Is this appropriate: will CT take my life?

Keen JD.

AJR Am J Roentgenol. 2011 Feb;196(2):W217; author reply W218. doi: 10.2214/AJR.09.3316. No abstract available.

PMID:
21257868
16.

Promoting screening mammography: insight or uptake?

Keen JD.

J Am Board Fam Med. 2010 Nov-Dec;23(6):775-82. doi: 10.3122/jabfm.2010.06.100065.

17.

Case 15-2010: Mammography in elderly women.

Keen JD.

N Engl J Med. 2010 Sep 23;363(13):1288; author reply 1288. doi: 10.1056/NEJMc1008116. No abstract available.

PMID:
20860516
18.

Where is the evidence: does computer-aided overdiagnosis save lives?

Keen JD.

Radiology. 2010 Mar;254(3):989. doi: 10.1148/radiol.091879. No abstract available.

PMID:
20177111
19.

What is the point: will screening mammography save my life?

Keen JD, Keen JE.

BMC Med Inform Decis Mak. 2009 Apr 2;9:18. doi: 10.1186/1472-6947-9-18.

20.

Nonmammographic screening for breast cancer.

Keen JD.

JAMA. 2008 Oct 1;300(13):1515-6; author reply 1516-7. doi: 10.1001/jama.300.13.1515-b. No abstract available.

PMID:
18827205
21.

How does age affect baseline screening mammography performance measures? A decision model.

Keen JD, Keen JE.

BMC Med Inform Decis Mak. 2008 Sep 21;8:40. doi: 10.1186/1472-6947-8-40.

22.

Another way to think about insurance: government action distorts the market price with harmful side effects.

Keen JD.

J Am Coll Radiol. 2007 Jun;4(6):347-9. No abstract available.

PMID:
17544134
23.

Does the marginal benefit exceed the marginal cost?

Keen JD, Keen JE.

Radiology. 2007 Apr;243(1):299-300; author reply 300. No abstract available.

PMID:
17392264
24.

On measuring costs and profit.

Keen JD.

AJR Am J Roentgenol. 2006 May;186(5):E8; author reply E8. No abstract available.

PMID:
16632705
25.

Digital and film mammography.

Keen JD.

N Engl J Med. 2006 Feb 16;354(7):765-7; author reply 765-7. No abstract available.

PMID:
16482674
26.

Re: Appraising decision and cost-effective analyses.

Keen JD, Dunne PM, Keen RR, Langer BG.

J Vasc Interv Radiol. 2001 Oct;12(10):1235-6. No abstract available.

PMID:
11585894
27.

The cost-effectiveness of exclusion arteriography in extremity trauma.

Keen JD, Keen RR.

Cardiovasc Surg. 2001 Oct;9(5):441-7.

PMID:
11489646
28.

Proximity arteriography: cost-effectiveness in asymptomatic penetrating extremity trauma.

Keen JD, Dunne PM, Keen RR, Langer BG.

J Vasc Interv Radiol. 2001 Jul;12(7):813-21.

PMID:
11435537
29.

Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study.

Shearman AM, Ordovas JM, Cupples LA, Schaefer EJ, Harmon MD, Shao Y, Keen JD, DeStefano AL, Joost O, Wilson PW, Housman DE, Myers RH.

Hum Mol Genet. 2000 May 22;9(9):1315-20.

PMID:
10814713
30.

Factors affecting inverted repeat stimulation of recombination and deletion in Saccharomyces cerevisiae.

Lobachev KS, Shor BM, Tran HT, Taylor W, Keen JD, Resnick MA, Gordenin DA.

Genetics. 1998 Apr;148(4):1507-24.

31.

Hypermutability of homonucleotide runs in mismatch repair and DNA polymerase proofreading yeast mutants.

Tran HT, Keen JD, Kricker M, Resnick MA, Gordenin DA.

Mol Cell Biol. 1997 May;17(5):2859-65.

Supplemental Content

Support Center